Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-379-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1990-08-29 to 1992-03-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it was conducted according to EPA OTS 798.4100.
- Justification for type of information:
- Read across justification included in Section 13
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.4100 (Skin Sensitisation)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The first-choice method according to REACH Annex VII §8.3, the Murine Local Lymph Node Assay, is known to give false positive results with hydrocarbon substances.
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Sasco, Inc., Omaha, Nebraska
- Age at study initiation: young adult
- Weight at study initiation: 300 to 500 grams
- Housing: individually housed in stainless steel, wire mesh bottom cages
- Diet: fresh Agway certified guinea pig feed provided ad libitum, throughout both acclimation and study periods
- Water: provided ad libitum via automatic watering system
- Acclimation period: 14 days for induction phase animals; 7 days for dose selections phase animals
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 26 degrees celsius
- Humidity (%): 40 to 70%
- Air changes (per hr): no less than ten changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/ 12 hours dark
IN-LIFE DATES: From: 1990-08-29 To: 1990-10-12 - Route:
- epicutaneous, occlusive
- Vehicle:
- other: Mineral oil
- Concentration / amount:
- Of test substance at:
Dose selection (irritation) phase: undiluted F-133, 1:2 v/v, 1:4 v/v, and 1:8 v/v F-133
Induction phase: undiluted
Challenge phase: 1:4 v/v - Route:
- epicutaneous, occlusive
- Vehicle:
- other: Mineral oil
- Concentration / amount:
- Of test substance at:
Dose selection (irritation) phase: undiluted F-133, 1:2 v/v, 1:4 v/v, and 1:8 v/v F-133
Induction phase: undiluted
Challenge phase: 1:4 v/v - No. of animals per dose:
- Of test substance at:
Dose selection phase: six animals
Induction phase and challenge phase: ten animals - Details on study design:
- RANGE FINDING TESTS: Six guinea pigs were used for the dose selection phase. Each animal was dosed with either undiluted, or 1:2 v/v, 1:4 v/v,
or 1:8 v/v mineral oil dilutions. The respective dilutions were applied to four pads, placed on the shaved areas, and occlusively wrapped. the
wrappings were removed after six hours and the skin was scored using the Draize method after 24 hours.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: three
- Exposure period: 6 hours
- Test groups: one group of ten guinea pigs dosed with 0.5 ml of undiluted F-133
- Control group: one group of 10 guinea pigs were dosed with 0.3% DNCB in 80% ethanol/water and served as the positive control;
one group of 4 guinea pigs were dosed with 0.5 mL of undiluted test substance to serve as the challenge control; one group of 4 guinea pigs
were dosed with mineral oil to serve as the vehicle control group
- Site: shaved strip of hair along one side of the dorsal midline
- Frequency of applications: one 6 hour exposure per week
- Duration: 3 weeks
- Concentrations: undiluted test article
B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day(s) of challenge: the challenge phase took place 14 days following the last induction application
- Exposure period: 6 hours
- Test groups: the induction/challenge group consists of 10 guinea pigs dosed with a 1:4 F-133 dilution of the test article
- Control group: four guinea pigs treated with 1:4 dilution of F-133 in mineral oil as challenge control, ten guinea pigs treated with 0.2% DNCB in 80% ethanol/water as induction/ challenge positive control, four guinea pigs treated with 0.2% DNCB in 80% ethanol/water as challenge control,
four guinea pigs in the mineral oil as vehicle control
- Site: shaved strip of hair along one side of the dorsal midline on the opposite side from the induction test site.
- Concentrations: 1:4 dilution of F-133
- Evaluation (hr after challenge): 24 and 48 hours after exposure
- Challenge controls:
- 1:4 dilution of F-133 challenge control; 0.2% DNCB challenge control
- Positive control substance(s):
- yes
- Remarks:
- 1,4 dinitrochlorobenzene (2,4 DNCB)
- Positive control results:
- DNCB induced an appropriate positive response in the induction and challenge phases and is considered a delayed contact sensitizer, under the conditions of this test.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 4.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 0.2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 3.8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 0.2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 3.8.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 4.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0.2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 3.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 0.2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 3.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- During the challenge phase, exposure of a 1:4 dilution of thermocracked kerosine to induction phase test animals did not yield higher response grades, severity, or incidence than those associated with the naive challenge control group exposed to thermocracked kerosine.
During the challenge phase, exposure of 0.2% DNCB to induction phase positive control animals elicited significantly higher response grades, severity indices, and incidence over the naive DNCB challenge control group. This indicates an appropriate positive response.
The vehicle irritation control group was free of dermal irritation during the challenge phase therefore, mineral oil used as a dilutant is not an irritant.
Therefore, under the conditions of this study, F-133 is not considered a delayed contact sensitizer. - Executive summary:
In a dermal sensitisation study using thermocracked kerosine in mineral oil, male young adult Pig/Hartley guinea pigs were tested using a modified Buehler technique.
During the challenge phase, a second exposure of a 1:4 dilution of thermocracked kerosine to induction test animals did not yield higher response grades, severity, or incidence than those associated with the naive challenge control group exposed to thermocracked kerosine. During the challenge phase, exposure of 0.2% DNCB to induction positive control animals elicited significantly higher response grades, severity indices, and incidence over the naive DNCB challenge control group. The vehicle irritation control group was free of dermal irritation during the challenge phase. Therefore, under the conditions of this study, thermocracked kerosine is not considered a delayed contact sensitiser and DNCB induced an appropriate positive response.
This study received a Klimisch score of 1 and is classified as reliable without restriction because it was conducted according to EPA OTS 798.4100.
Reference
The
scores after the challenge treatment are summarised below
Group |
Time |
Response Grade Range |
Incidence |
F-133 Induction/Challenge group |
24 h |
0 |
0/10 |
|
48 h |
0 |
0/10 |
F-133 Challenge control |
24 h |
0 |
0/4 |
|
48 h |
0 |
0/4 |
DNCB Induction/Challenge positive control |
24 h |
3-5 |
10/10 |
|
48 h |
2-4 |
10/10 |
DNCB Challenge control |
24 h |
0-1 |
3/4 |
|
48 h |
0-1 |
3/4 |
Vehicle control |
24 h |
0 |
0/4 |
|
48 h |
0 |
0/4 |
On
the basis of the above response, the test material was not sensitizing.
No. with positive reactions:
Induction Phase:
Treatment 1 Scores: 9 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 1 Scores: 9 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Treatment 2 Scores: 10 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 2 Scores: 10 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Treatment 3 Scores: 10 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 3 Scores: 10 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Challenge Scores:
0 out of 10 (Induction/Challenge test group); dose: 0.5 ml of F-133 1:4 dilution in mineral oil
0 out of 4 (F-133 Challenge Control); dose: 0.5 ml of F-133 1:4 dilution in mineral oil
10 out of 10 (DNCB Induction/Challenge Group); dose: 0.5 ml of 0.3% DNCB in 80% ethanol
3 out of 4 (DNCB Challenge Control); dose: 0.5 ml of 0.2% DNCB in 80% ethanol
0 out of 4 (Vehicle Challenge Control); dose: 0.5 ml of mineral oil
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Data on related substances have been used to 'read-across' and predict the hazard properties. A 'read-across' justification document can be found in section 13.
In the key dermal sensitisation study (Klimisch score=1; ARCO, 1992), thermocracked kerosine in mineral oil was tested on male young adult Pig/Hartley guinea pigs using a modified Buehler technique. During the challenge phase, a second exposure of a 1:4 dilution of thermocracked kerosine to induced test animals did not yield higher response grades, severity, or incidence than those associated with the naive challenge control group exposed to thermocracked kerosine. During the challenge phase, exposure of 0.2% DNCB to induction positive control animals elicited significantly higher response grades, severity indices, and incidence over the naive DNCB challenge control group. The vehicle irritation control group was free of dermal irritation during the challenge phase. Therefore, under the conditions of this study, thermocracked kerosine is not considered a delayed contact sensitiser and DNCB induced an appropriate positive response.
Migrated from Short description of key information:
A sample of hydrodesulphurised kerosine was not a skin sensitiser when tested in guinea pigs by the Buehler method
Respiratory sensitisation
Endpoint conclusion
- Additional information:
This endpoint is not a REACH requirement.
Migrated from Short description of key information:
This endpoint is not a REACH requirement.
Justification for classification or non-classification
Kerosines are not considered skin sensitisers based on the information presented above. Therefore, kerosines do not meet the criteria for classification as a dermal sensitiser under EU CLP Regulation (EC No. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.